Radionuclide‐Activated Luminescence for Cancer Theranostics
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202500296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Jingchao Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, 400042, China. Hauptthemen laut MEDLINE: Neoplasms, Theranostic Nanomedicine, Radioisotopes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National High-Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Within dielectric media, charged particles emitted from medical radionuclides induce polarization of surrounding molecules, which subsequently generate Cerenkov luminescence (CL) upon returning to their ground state. This CL emission confers clinically approved radiotracers with distinctive potential for applications in phototheranostics. However, the utility of CL in vivo has been severely constrained by its ultraviolet‐weighted emission spectrum and extremely low photon flux, particularly in living imaging and triggering photodynamic therapy. Certain optical probes, encompassing fluorescent agents and nanoparticle scintillators, can be activated by radionuclides to generate red‐shifted emissions with amplified luminescence intensity compared to CL. This phenomenon, termed radionuclide‐activated luminescence (RL), represents a promising strategy for enhancing radionuclide‐induced tumor phototheranostic outcomes. This review systematically summarizes the advances in RL technology, highlighting the development of various RL probes and their innovative applications in laser‐free optical bioimaging and cancer phototherapy. It further delves into the confronting challenges and prospects of RL technology, aiming to provide a comprehensive overview and practical insights to advance the integration of radiotheranostics and phototheranostics in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, 400042, China.
- Department of Prevention & Healthcare, Southwest Hospital, Army Medical University, Chongqing, 400038, China.
- State Key Laboratory of Silicon and Advanced Semiconductor Materials, Institute for Composites Science Innovation, School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, China.
- State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
- Theranostics and Translational Research Center, National Infrastructures for Translational Medicine, Institute of Clinical Medicine &, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Acade…
ORCID-Profile: Xianzhong Zhang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National High-Level Hospital Clinical Research Funding
- National Key Research and Development Program of China
Zitieren
APA
Li, J., Lyu, S., Li, C. A., Tang, Y., Wang, F., Wang, Q., Li, X., Xu, G., Li, H., Zhang, Y., Guo, Z., Chen, X., & Zhang, X. (2025). Radionuclide‐Activated Luminescence for Cancer Theranostics. Chemistry – A European Journal. https://doi.org/10.1002/chem.202500296
Vancouver
Li J, Lyu S, Li CA, Tang Y, Wang F, Wang Q, et al. Radionuclide‐Activated Luminescence for Cancer Theranostics. Chemistry – A European Journal. 2025. doi:10.1002/chem.202500296
BibTeX
@article{Li2025,
author = {Li, Jingchao and Lyu, Shengji and Li, Cheng-Ao and Tang, Yi and Wang, Fangyang and Wang, Qiang and Li, Xin and Xu, Guo and Li, Hongqing and Zhang, Yueying and Guo, Zhide and Chen, Xiao and Zhang, Xianzhong},
title = {Radionuclide‐Activated Luminescence for Cancer Theranostics},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202500296}
}
EUVIMED